2.08-14.0 Work Plan Implementation Summary
2.08-13.1 Call For Action
2.08-13.0 TB-HIV Roundtable
2.08-12.0 Global Plan Progress Summary
2.08-11.3 DST policy
2.08-11.2 Line Probe Assays
2.08-11.1 GLI Synopsis FINAL
2.08-11.0 Diganostics and GLI in the field
2.08-10.1 2nd line drugs Background Paper
2.08-10.0 2nd-line Drugs Summary